81930-38-3 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
Explanation
It is a modified version of the parent compound, cyclohexanedione, with additional functional groups.
Explanation
The compound is utilized in the production of various pharmaceuticals and organic compounds due to its reactivity and reducing properties.
Explanation
The compound exists in a liquid state and has a yellowish color.
Explanation
The compound has a noticeable and sweet-smelling odor.
Explanation
The compound can dissolve in water, alcohol, and ether, which are common solvents used in chemical reactions and laboratory procedures.
Explanation
The compound is known for its strong reducing properties, allowing it to react with other chemicals to form a variety of products.
Explanation
Due to its reactivity and potential hazards, it is essential to take necessary safety measures when working with 1,3-Cyclohexanedione, 2-acetyl-5-methylin a laboratory setting.
Derivative of cyclohexanedione
Yes
Common use
Synthesis of pharmaceuticals and organic compounds
Physical state
Yellowish liquid
Odor
Strong, sweet
Solubility
Soluble in water, alcohol, and ether
Chemical reactivity
Powerful reducing agent
Safety precautions
Handle with caution and follow proper safety protocols
Check Digit Verification of cas no
The CAS Registry Mumber 81930-38-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,9,3 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 81930-38:
(7*8)+(6*1)+(5*9)+(4*3)+(3*0)+(2*3)+(1*8)=133
133 % 10 = 3
So 81930-38-3 is a valid CAS Registry Number.
81930-38-3Relevant articles and documents
Tetrahydroindazole inhibitors of CDK2/cyclin complexes
Lee, Jae Chul,Hong, Kwon Ho,Becker, Andreas,Tash, Joseph S.,Sch?nbrunn, Ernst,Georg, Gunda I.
, (2021/02/09)
Over 50 tetrahydroindazoles were synthesized after 7-bromo-3,6,6-trimethyl-1-(pyridin-2-yl)-5,6,7,7a-tetrahydro-1H-indazol-4(3aH)-one (3) was identified as a hit compound in a high throughput screen for inhibition of CDK2 in complex with cyclin A. The activity of the most promising analogues was evaluated by inhibition of CDK2 enzyme complexes with various cyclins. Analogues 53 and 59 showed 3-fold better binding affinity for CDK2 and 2- to 10-fold improved inhibitory activity against CDK2/cyclin A1, E, and O compared to screening hit 3. The data from the enzyme and binding assays indicate that the binding of the analogues to a CDK2/cyclin complex is favored over binding to free CDK2. Computational analysis was used to predict a potential binding site at the CDK2/cyclin E1 interface.
SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
-
Page/Page column 24-25, (2008/12/06)
The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating mammals suffering from the condition of being overweight.
Antiviral and Antimicrobial Activity of 2,4-Diacylphloroglucinols, 2-Acylcyclohexane-1,3-diones and 2-Carboxamidocyclohexane-1,3-diones
Tada, Masahiro,Takakuwa, Takako,Nagai, Masashi,Yoshii, Takao
, p. 3061 - 3063 (2007/10/02)
-